Robert Anderson - Aehr Test Independent Director
| AEHR Stock | USD 10.59 0.23 2.22% |
Director
Mr. Robert R. Anderson is no longer Independent Director of the Company, effective October 26, 2017. Mr. Anderson currently is a director of MKS Instruments, Inc., a semiconductor components and equipment supplier. Mr. Anderson also serves as a director for Energetiq Technology, Inc., a private company. Mr. Anderson was cofounder, Chairman of the Board, Chief Financial Officer and Chief Operating Officer of KLA Instruments, a supplier of process control and yield management solutions for the semiconductor and related nanoelectronics industries, from 1975 through 1994. Mr. Anderson is a graduate of Bentley University and served as a trustee of Bentley University from 1993 through 2004. since 2000.
| Age | 78 |
| Tenure | 24 years |
| Address | 400 Kato Terrace, Fremont, CA, United States, 94539 |
| Phone | 510 623 9400 |
| Web | https://www.aehr.com |
Aehr Test Management Efficiency
The company has return on total asset (ROA) of 0.0885 % which means that it generated a profit of $0.0885 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1986 %, meaning that it created $0.1986 on every $100 dollars invested by stockholders. Aehr Test's management efficiency ratios could be used to measure how well Aehr Test manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aehr Test's Return On Tangible Assets are relatively stable compared to the past year. As of 04/23/2024, Return On Capital Employed is likely to grow to 0.20, while Return On Equity is likely to drop 0.09. At this time, Aehr Test's Intangibles To Total Assets are relatively stable compared to the past year. As of 04/23/2024, Return On Assets is likely to grow to 0.18, while Debt To Assets are likely to drop 0.05.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Mary Szela | Sunnova Energy International | 52 | |
| Brian Daniels | Sunnova Energy International | 55 | |
| Eivind Kolding | Sunnova Energy International | N/A | |
| Gerald Risk | Sunrun Inc | 48 | |
| Bruno Angelici | Sunnova Energy International | 68 | |
| Sylvie Gregoire | Sunnova Energy International | 53 | |
| Katherine AugustdeWilde | Sunrun Inc | 70 | |
| Soeren Pedersen | Sunnova Energy International | 50 | |
| Steven Vassallo | Sunrun Inc | 45 | |
| Anne Kverneland | Sunnova Energy International | 58 | |
| Richard Wong | Sunrun Inc | 47 | |
| Thomas Koestler | Sunnova Energy International | 63 | |
| Alan Ferber | Sunrun Inc | 49 | |
| Jameson McJunkin | Sunrun Inc | 39 | |
| Liz Hewitt | Sunnova Energy International | 58 | |
| Leslie Dach | Sunrun Inc | 63 | |
| Stig Stroebaek | Sunnova Energy International | 51 | |
| Liselotte Hyveled | Sunnova Energy International | 49 | |
Management Performance
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0885 |
Aehr Test Systems Leadership Team
Elected by the shareholders, the Aehr Test's board of directors comprises two types of representatives: Aehr Test inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aehr. The board's role is to monitor Aehr Test's management team and ensure that shareholders' interests are well served. Aehr Test's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aehr Test's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Donald II, VP Engineering | ||
| Kunio Sano, President of Aehr Test Systems Japan K.K. | ||
| Avijit RayChaudhuri, Executive RD | ||
| Howard Slayen, Independent Director | ||
| Carl Buck, VP of Marketing | ||
| Chris Siu, Executive CFO | ||
| Robert Anderson, Independent Director | ||
| Donald Richmond, Vice President - Engineering | ||
| John Schneider, Director | ||
| Todd Kehrli, IR Contact Officer | ||
| Rhea Posedel, Founder and Chairman | ||
| William Elder, Independent Director | ||
| Adil Engineer, Chief Officer | ||
| Kenneth Spink, Interim CFO | ||
| David Hendrickson, VP of Engineering | ||
| Laura Oliphant, Director | ||
| Mario Rosati, Director | ||
| Mark Allison, VP of Worldwide Sales | ||
| Gayn Erickson, CEO and President and Director | ||
| David Fucci, Vice President - Operations | ||
| Vernon Rogers, Executive Vice President of Sales and Marketing |
Aehr Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aehr Test a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0885 | ||||
| Profit Margin | 0.21 % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 258.28 M | ||||
| Shares Outstanding | 28.91 M | ||||
| Shares Owned By Insiders | 5.84 % | ||||
| Shares Owned By Institutions | 69.60 % | ||||
| Number Of Shares Shorted | 5.61 M | ||||
| Price To Earning | 70.48 X |
Pair Trading with Aehr Test
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.Moving together with Aehr Stock
| 0.75 | INTC | Intel Earnings Call This Week | PairCorr |
Moving against Aehr Stock
| 0.89 | AA | Alcoa Corp Financial Report 17th of July 2024 | PairCorr |
| 0.87 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
| 0.81 | MMM | 3M Company Earnings Call This Week | PairCorr |
| 0.77 | CAT | Caterpillar Earnings Call This Week | PairCorr |
| 0.72 | CVX | Chevron Corp Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.
The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Aehr Test Systems information on this page should be used as a complementary analysis to other Aehr Test's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Aehr Stock analysis
When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Aehr Test's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aehr Test. If investors know Aehr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aehr Test listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.538 | Earnings Share 0.52 | Revenue Per Share 2.506 | Quarterly Revenue Growth (0.56) | Return On Assets 0.0885 |
The market value of Aehr Test Systems is measured differently than its book value, which is the value of Aehr that is recorded on the company's balance sheet. Investors also form their own opinion of Aehr Test's value that differs from its market value or its book value, called intrinsic value, which is Aehr Test's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aehr Test's market value can be influenced by many factors that don't directly affect Aehr Test's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aehr Test's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aehr Test is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aehr Test's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.